MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
17.00
-0.15
-0.87%
After Hours: 16.95 -0.05 -0.30% 18:32 12/31 EST
OPEN
17.22
PREV CLOSE
17.15
HIGH
17.31
LOW
16.92
VOLUME
1.70M
TURNOVER
--
52 WEEK HIGH
21.73
52 WEEK LOW
5.28
MARKET CAP
3.11B
P/E (TTM)
-23.0884
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at WVE last week (1222-1226)?
Weekly Report · 12/29/2025 09:14
Largest borrow rate increases among liquid names
TipRanks · 12/23/2025 13:45
Weekly Report: what happened at WVE last week (1215-1219)?
Weekly Report · 12/22/2025 09:14
Wave Life Sciences (WVE) Price Target Increased by 60.82% to 32.70
NASDAQ · 12/21/2025 21:48
Wave Life Sciences Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 12/19/2025 16:30
Wave Life Sciences Price Target Raised to $30.00/Share From $22.00 by HC Wainwright & Co.
Dow Jones · 12/19/2025 16:30
HC Wainwright & Co. Maintains Buy on WAVE Life Sciences, Raises Price Target to $30
Benzinga · 12/19/2025 16:21
Wave Life Sciences: Differentiated INHBE-Targeting Obesity Therapy WVE-007 Supports Buy Rating and Upside Potential
TipRanks · 12/19/2025 15:45
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.